DoctoratClosing soon

ASSISTANT (tenure track) or ASSOCIATE PROFESSOR in the field of Pharmaceutical Technology and Biopharmacy

EURAXESS hosting organisation · Plusieurs pays européens

The School of Pharmaceutical Sciences at the University of Geneva offers a dynamic and highly stimulating research environment. It has been one of the world's leading schools of pharmaceutical sciences for several years, and boasts a new, high-quality infrastructure enabling it to host collaborations under the best possible conditions. The School invites applications for the position of Assistant Professor (tenure-track) or Associate Professor in the field of pharmaceutical technology and biopharmacy. The successful candidate will establish a competitive research program focused on advanced pharmaceutical technology processes and biopharmacy, including contemporary manufacturing and development methods (for conventional drug and newer therapeutic modalities), 3D printing and bioprinting, h

At a glance

Where: Multiple European countries
Deadline: 2026-09-23
Funding: Fully funded (as stated on programme page)
Board: EURAXESS

Who can apply

Criteria stated by the funder on the official source.

Nationality

EURAXESS vacancies rarely print a nationality table. Confirm whether applicants from Tunisia can apply and whether a residence/work permit pathway exists on the employer page.

Non indiqué

Education

Research Field Other Education Level PhD or equivalent Skills/Qualifications REQUIREMENTS - Doctorate in pharmaceutical sciences or equivalent qualification. - Track record of obtaining extramural funding from national and/or international funding agencies and through industrial collaborations. - Track record of publications in leading international journals. Must be fluent in English and willing to learn French. Languages ENGLISH Level Excell

Non indiqué

Funding and what it does not cover

The programme page describes substantial scholarship / funding coverage. Exact monthly amounts and inclusions must match the official notice for the current call.